-
Biotechnology Market Set to Witness Significant Growth by 2026-2033 | Amgen Inc., GlaxoSmithKline
06 Feb 2026 10:40 GMT
… Covered:
◘ Abbott Laboratories
◘ Amgen Inc.
◘ GlaxoSmithKline
◘ Johnson and Johnson
◘ Merck
◘ Novartis …
-
Modeling Best Practices of Medically Integrated Pharmacies to Improve Treatment Monitoring and Therapy Adherence in Patients With HR+/HER2- Breast Cancer
04 Feb 2026 05:09 GMT
… , FHOPA
Consultant/Advisory Board: Glaxo Smith Kline, Regeneron
Research Grant: AstraZeneca, Janssen …
-
Zantac defendants fight for Phila. judge to rule on shaky evidence
06 Feb 2026 20:01 GMT
… practicing litigator.”
The litigation against GlaxoSmithKline and others began when Valisure …
-
HPV vaccine rollout a mirage; why menstrual hygiene may be India’s low-hanging cervical cancer key
06 Feb 2026 18:39 GMT
… giants such as Merck and GlaxoSmithKline, but it has so far …
-
Have originator medicines’ list prices started to drop in the US?
06 Feb 2026 16:06 GMT
… ), Boehringer Ingelheim, Genentech, Gilead Sciences, GlaxoSmithKline (GSK), Merck & Co. (MSD …
-
Generic Drugs Market Size to Reach USD 762.48 Billion by 2035 Driven by Rising Chronic Disease Burden and Cost-Control Focus
06 Feb 2026 13:58 GMT
… wide range of generic drugs.
GlaxoSmithKline Plc. (GSK): GSK maintains a …
-
FcRn blockade yields mixed efficacy results in rheumatology
06 Feb 2026 13:31 GMT
… salary support from Amgen, AstraZeneca, GlaxoSmithKline, Horizon, Janssen, Eli Lilly, Medimmune …
-
Oaklin acquires boutique M&A specialist BTD Consulting
06 Feb 2026 05:36 GMT
… : Centrica, Coca Cola, E.ON, GlaxoSmithKline, Novartis and Unilever, as well …
-
<![CDATA[TrumpRx Launch Brings Savings—and Uncertainty]]>
06 Feb 2026 04:06 GMT
… , Eli Lilly, Genentech, Gilead Sciences, GlaxoSmithKline, Merck & Co, Novartis, Novo …
-
<![CDATA[Optimising ocular surface health in glaucoma: From awareness to action]]>
05 Feb 2026 23:00 GMT
… -Sankyo/AstraZeneca, DMG, Fidia, GlaxoSmithKline, Kala Bio, Novaliq, Nordic Pharma …